From professional translators, enterprises, web pages and freely available translation repositories.
including rheumatoid arthritis, systemic lupus erythematosus, scleroderma, sjögren’ s syndrome and dermatomyositis/ polymyositis.
sealhulgas reumatoidartriit, süsteemne erütematoosne luupus, skleroderma, sjögreni sündroom ja dermato - / polümüosiit.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
these autoimmune diseases include rheumatoid arthritis, systemic lupus erythematosus, scleroderma, sjögren's syndrome and dermatomyositis/ polymyositis.
sellised autoimmuunsed haigused on reumatoidartriit, süsteemne erütematoosne luupus, sklerodermia, sjögreni sündroom ja dermatomüosiit/ polümüosiit.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
rhabdomyolysis, which can be associated with acute renal failure secondary to myoglobinuria, myopathy (see section 4.4); myositis, polymyositis.
rabdomüolüüs, mis võib esineda koos müoglobinuuriast tingitud akuutse neerupuudulikkusega, müopaatia (vt lõik 4.4); müosiit, polümüosiit.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
have known autoimmune disease, including rheumatoid arthritis, systemic lupus erythematosus, scleroderma, sjögren’s syndrome and dermatomyositis/polymyositis;
teadaolev autoimmuunne haigus, sealhulgas reumatoidartriit, süsteemne erütematoosne luupus, skleroderma, sjögreni sündroom ja dermato-/polümüosiit;
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
you should inform your doctor if you have an autoimmune disease, such as rheumatoid arthritis, systemic lupus erythematosus, scleroderma, sjögren's syndrome or dermatomyositis/polymyositis.
kui teil esineb mõni autoimmuunne haigus, näiteks reumatoidartriit, süsteemne erütematoosne luupus, sklerodermia, sjögreni sündroom või dermatomüosiit/polümüosiit, peate sellest arstile rääkima.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
among rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and plaque psoriasis patients in placebo-controlled, active-controlled, and open-label trials of enbrel, serious adverse events reported included malignancies (see below), asthma, infections (see below), heart failure, myocardial infarction, myocardial ischaemia, chest pain, syncope, cerebral ischaemia, hypertension, hypotension, cholecystitis, pancreatitis, gastrointestinal haemorrhage, bursitis, confusion, depression, dyspnoea, abnormal healing, renal insufficiency, kidney calculus, deep vein thrombosis, pulmonary embolism, membranous glomerulonephropathy, polymyositis, thrombophlebitis, liver damage, leucopenia, paresis, paresthesia, vertigo, allergic alveolitis, angioedema, scleritis, bone fracture, lymphadenopathy, ulcerative colitis, intestinal obstruction, eosinophilia, haematuria, and sarcoidosis.
tõsised kõrvaltoimed, millest on teatatud kliiniliste uuringute käigus platseebo- kontrollitud, aktiivse kontrolliga ja avatud uuringute käigus teatati enbreliga ravitud reumatoidartriidi, psoriaatilise artriidi, anküloseeriva spondüliidiga ja psoriaasiga patsientidel järgmistest tõsistest kõrvaltoimetest: pahaloomulised kasvajad (vt allpool), astma, infektsioonid (vt
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.